Top

Published in:

Open Access 01-12-2015 | Letter to the Editor

Focusing on rare diseases in China: are we there yet?

Authors: Li Yang, Chang Su, Ashley M. Lee, Harrison X. Bai

Published in: Orphanet Journal of Rare Diseases | Issue 1/2015

Abstract

The Chinese researchers have made significant progress in studying rare diseases in the recent years. From 2000 to 2014, 269 out of 1892 clinically relevant original research papers published on high impact journals by Chinese institutions, and 2678 out of 6040 clinical trials conducted by Chinese institutions and registered at ClinicalTrial.gov are focused on rare diseases. The number of research papers and of clinical trials has shown a steady trend of increase. Creating public databases for rare disease will escalate progress in rare disease and enable multicenter studies.

Wang JB, Guo JJ, Yang L, Zhang YD, Sun ZQ, Zhang YJ. Rare diseases and legislation in China. Lancet. 2010;375(9716):708–9.CrossRefPubMed

Hidden Cost of Rare Diseases. <http://www.chinadaily.com.cn/cndy/2011-03/31/content_12252709.htm> Accessed 03/31/2011.

Chinese organization for rare disorders: China development brief <http://chinadevelopmentbrief.cn/directory/chinese-organization-rare-disorders/>.

“Communication from the Commision to the European Parlimaent, the Council, the European Economic and Social Commitee and the Commitee of the Regions on Rare Disease: Europe’s Challenges” . European Commission. <http://ec.europa.eu/health/ph_threats/non_com/docs/rare_com_en.pdf> Accessed 11/11/2008.

Lappalainen I, Almeida-King J, Kumanduri V, et al. The European Genome-phenome Archive of human data consented for biomedical research. Nat Genet. 2015;47(7):692–5.CrossRefPubMed

Title: Focusing on rare diseases in China: are we there yet?
Authors: Li Yang
Chang Su
Ashley M. Lee
Harrison X. Bai
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: Orphanet Journal of Rare Diseases / Issue 1/2015
Electronic ISSN: 1750-1172
DOI: https://doi.org/10.1186/s13023-015-0361-3

At a glance: The STEP trials

Springer Medicine

Focusing on rare diseases in China: are we there yet?

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2015

Decreased performance in IDUA knockout mouse mimic limitations of joint function and locomotion in patients with Hurler syndrome

Recommendations for the development of rare disease drugs using the accelerated approval pathway and for qualifying biomarkers as primary endpoints

Friedreich ataxia in Norway – an epidemiological, molecular and clinical study

Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C

Review and comparison of clinical evidence submitted to support European Medicines Agency market authorization of orphan-designated oncological treatments

Rare genetic disease in China: a call to improve clinical services